Polar Capital Global Healthcare

Results of Audit Tender Process
RNS Number : 7944G
Polar Capital Global Health Tst PLC
27 November 2020

Polar Capital Global Healthcare Trust plc ("the Company")


Legal Entity Identifier: 549300YV7J2TWLE7PV84



27 November 2020



Results of Audit Tender Process

The Company announces that following a competitive tender process under the supervision of the Audit Committee, the Board has decided to retain the services of PricewaterhouseCoopers LLP as the external auditor to both the Company and the Company's subsidiary, PCGH ZDP Plc.

The tender process has been carried out in compliance with the Competition and Markets Authority regulations, applicable EU requirements and Financial Reporting Council guidance.

Following the Audit Committee's recommendation, the Board will propose the re-appointment of PricewaterhouseCoopers LLP as external auditors for the year ending 30 September 2021 at the Company's Annual General Meeting to be held in January 2021. PricewaterhouseCoopers LLP has been auditor of the Company since launch in 2010.

The Board would like to thank the four audit firms that participated in the audit tender process.

PricewaterhouseCoopers LLP has confirmed its continued independence and willingness to be re-appointed as external auditor to both the Company and the Company's subsidiary.



For further information, please contact:

Polar Capital Global Healthcare Trust plc


Neal Ransome

Chairman of the Audit Committee


Tracey Lago, FCG

Polar Capital Secretarial Services Ltd

Company Secretary





Tele. +44 (0)20 7227 2700


Email. cosec@polarcapital.co.uk




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.